Aventis Pharma is part of the Sanofi-Aventis group. Its manufacturing portfolio contains medicines for several therapeutic areas including cardiovascular, thrombotic, metabolic disorders, oncology, disorders of the central nervous system, internal medicine.
“In our sector, it is imperative to be the first to obtain competitive advantage and an ROI on our research studies. Informatica became a valuable ally for daily reporting and thus guarantees our teams the optimum responsiveness and effectiveness.”
— Alain Afios, Head of Data Processing, R&D, Aventis
Develop new drugs as soon as possible, with early detection of factors impacting market entry.
Accelerate the company’s decision-making capability.
Automate the gathering of research data from 11 discrete systems.
Standardize research data for faster reporting.
Speed distribution of reports and metrics to decision-makers.
Improved early detection of R&D issues.
Significantly decreased time-to-market.
Ensured researchers have timely access to accurate, up-to-date data.
Quintiles gained enhanced data accuracy, timeliness, and completeness and faster time to market for its pharmaceuticals
The Cancer Council of New South Wales accurately identified patient records across 54 pathology laboratories
Informatica Cloud enabled Nobel Biocare to have single, consistent view of global customer purchase patterns across nine languages.